Literature DB >> 28168356

Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme.

Jia-Bin Wang1, Feng-Hua Liu2, Jian-Hang Chen1, Hai-Tao Ge1, Lu-Yan Mu3, Hong-Bo Bao1,4,5, Zhi-Guo Lin6.   

Abstract

BACKGROUND: Long noncoding RNAs (lncRNAs) can act as competitive endogenous RNAs (ceRNAs) to compete with mRNAs for binding miroRNAs (miRNAs). The dysregulated triplets, composed by mRNAs, lncRNAs, and miRNAs, contributed to the development and progression of diseases, such as cancer. However, the roles played by triplet biomarkers are not fully understand in glioblastoma multiforme (GBM) patient survival.
OBJECTIVES: Here, we constructed a differential triplet interaction network (TriNet) between GBM and normal tissues and identified GBM survival related triplets.
METHODS: Four significantly dysregulated modules, enriched differentially expressed molecules, were identified by integrating affinity propagation method and hypergeometric method. Furthermore, knockdown of TP73-AS1 was implemented by siRNA and the expression of RFX1 was examined in U87 cells by qRT-PCR. The apoptosis of U87 cells was investigated using MTT assay and Acridine orange/Ethidium bromide (AO/EB) assay.
RESULTS: We randomly split GBM samples into training and testing sets, and found that these four modules can robustly and significantly distinguish low- and high-survival patients in both two sets. By manually curated literatures for triplets mediated by core interactions, we found that members involved tumor invasion, proliferation, and migration. The dysregulated triplets may cause the poor survival of GBM patients. We finally experimentally verified that knockdown of TP73-AS1, an lncRNA of one triplet, could not only reduce the expression of RFX1, an mRNA of this triplet, but also induce apoptosis in U87 cells.
CONCLUSIONS: These results can provide further insights to understand the functions of triplet biomarkers that associated with GBM prognosis.

Entities:  

Keywords:  CeRNA network; Glioblastoma; TP73-AS1; lncRNAs; miRNAs

Mesh:

Year:  2017        PMID: 28168356     DOI: 10.1007/s00432-016-2332-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  61 in total

Review 1.  Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.

Authors:  Jayson I L Bastien; Katharine A McNeill; Howard A Fine
Journal:  Cancer       Date:  2014-09-23       Impact factor: 6.860

Review 2.  Towards developing biomarkers for glioblastoma multiforme: a proteomics view.

Authors:  Savita Jayaram; Manoj Kumar Gupta; Ravindra Varma Polisetty; William C S Cho; Ravi Sirdeshmukh
Journal:  Expert Rev Proteomics       Date:  2014-08-13       Impact factor: 3.940

3.  Up-regulation of microRNA-16 in Glioblastoma Inhibits the Function of Endothelial Cells and Tumor Angiogenesis by Targeting Bmi-1.

Authors:  Fanfan Chen; Lei Chen; Hua He; Weiyi Huang; Run Zhang; Peng Li; Yicheng Meng; Xiaodan Jiang
Journal:  Anticancer Agents Med Chem       Date:  2016       Impact factor: 2.505

4.  Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.

Authors:  Pengjun Wang; Zhongqiao Ren; Piyun Sun
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

Review 5.  Functional interactions among microRNAs and long noncoding RNAs.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Semin Cell Dev Biol       Date:  2014-06-02       Impact factor: 7.727

6.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

7.  A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation.

Authors:  Bart A Westerman; A Koen Braat; Nicole Taub; Marko Potman; Joseph H A Vissers; Marleen Blom; Els Verhoeven; Hans Stoop; Ad Gillis; Arno Velds; Wouter Nijkamp; Roderick Beijersbergen; Lukas A Huber; Leendert H J Looijenga; Maarten van Lohuizen
Journal:  J Exp Med       Date:  2011-12-05       Impact factor: 14.307

8.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

9.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations.

Authors:  Yang Li; Chengxiang Qiu; Jian Tu; Bin Geng; Jichun Yang; Tianzi Jiang; Qinghua Cui
Journal:  Nucleic Acids Res       Date:  2013-11-04       Impact factor: 16.971

10.  LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR.

Authors:  Jiyoung Kim; Kotb Abdelmohsen; Xiaoling Yang; Supriyo De; Ioannis Grammatikakis; Ji Heon Noh; Myriam Gorospe
Journal:  Nucleic Acids Res       Date:  2016-01-26       Impact factor: 16.971

View more
  8 in total

1.  Knockdown of lncRNA TP73-AS1 inhibits gastric cancer cell proliferation and invasion via the WNT/β-catenin signaling pathway.

Authors:  Yufeng Wang; Shuai Xiao; Bingyi Wang; Yang Li; Quanning Chen
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

Review 2.  Exploring the secrets of brain transcriptional regulation: developing methodologies, recent significant findings, and perspectives.

Authors:  Zhe Ding; Luyun Sun; Cen Yang; Aihua Liu; Fukai Bao
Journal:  Brain Struct Funct       Date:  2021-02-05       Impact factor: 3.270

3.  An Overview of the Computational Models Dealing with the Regulatory ceRNA Mechanism and ceRNA Deregulation in Cancer.

Authors:  Federica Conte; Giulia Fiscon; Pasquale Sibilio; Valerio Licursi; Paola Paci
Journal:  Methods Mol Biol       Date:  2021

4.  Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.

Authors:  Yun Ye; Su-Liang Li; Sheng-Yu Wang
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

5.  Inferences of individual drug responses across diverse cancer types using a novel competing endogenous RNA network.

Authors:  Yan Zhang; Xin Li; Dianshuang Zhou; Hui Zhi; Peng Wang; Yue Gao; Maoni Guo; Ming Yue; Yanxia Wang; Weitao Shen; Shangwei Ning; Yixue Li; Xia Li
Journal:  Mol Oncol       Date:  2018-07-14       Impact factor: 6.603

6.  Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity.

Authors:  Chun Feng; Jin-Ming Shen; Ping-Ping Lv; Min Jin; Li-Quan Wang; Jin-Peng Rao; Lei Feng
Journal:  Int J Biol Sci       Date:  2018-07-27       Impact factor: 6.580

Review 7.  RFX1: a promising therapeutic arsenal against cancer.

Authors:  Joby Issac; Pooja S Raveendran; Ani V Das
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

8.  Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.

Authors:  Depei Li; Jie Lu; Hong Li; Songtao Qi; Lei Yu
Journal:  Mol Med Rep       Date:  2019-04-24       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.